Shanghai Medicilon Inc. (SHA:688202)
107.64
+3.68 (3.54%)
At close: Sep 30, 2026
Shanghai Medicilon Employees
Shanghai Medicilon had 2,780 employees as of June 30, 2026. The number of employees increased by 276 or 11.02% since the number was reported on December 31, 2025.
Employees
2,780
Change
276
Growth
11.02%
Revenue / Employee
497.89K CNY
Profits / Employee
-37.17K CNY
Market Cap
14.16B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 2,780 | 276 | 11.02% |
| Dec 31, 2025 | 2,504 | 155 | 6.60% |
| Dec 31, 2024 | 2,349 | -251 | -9.65% |
| Dec 31, 2023 | 2,600 | -698 | -21.16% |
| Dec 31, 2022 | 3,298 | 858 | 35.16% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Nanjing Vazyme Biotech | 3,002 |
| Anhui Anke Biotechnology (Group) | 2,505 |
| Sinocelltech Group | 2,200 |
| Jinyu Bio-technology | 1,881 |
| GemPharmatech | 1,692 |
| Mabwell (Shanghai) Bioscience | 1,356 |
| BrightGene Bio-Medical Technology | 1,199 |
| Inner Mongolia Furui Medical Science | 946 |